Angina Prevalence and Provider Evaluation of Angina Relief (APPEAR)

This study is enrolling participants by invitation only.
Sponsor:
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
John A. Spertus, MD, MPH, Saint Luke's Health System
ClinicalTrials.gov Identifier:
NCT01705054
First received: September 25, 2012
Last updated: July 9, 2014
Last verified: July 2014

September 25, 2012
July 9, 2014
July 2013
September 2014   (final data collection date for primary outcome measure)
Seattle Angina Questionnaire [ Time Frame: One time cardiology office visit. ] [ Designated as safety issue: No ]
Percentage of patients with frequent angina (>1 episode/week) as measured by the Seattle Angina Questionnaire (SAQ).
Same as current
Complete list of historical versions of study NCT01705054 on ClinicalTrials.gov Archive Site
  • Quality of Life [ Time Frame: One time cardiology office visit. ] [ Designated as safety issue: No ]
    Evaluate the impact of frequent angina on Quality of Life (as measured by the SAQ)
  • Physician Perspective [ Time Frame: One time cardiology office visit. ] [ Designated as safety issue: No ]
    Identifying differences between patients' and cardiologists' assessment of angina control
  • Cardiology practices angina control. [ Time Frame: One time cardiology office visit. ] [ Designated as safety issue: No ]
    Evaluate the differences in angina control between cardiology practices.
Same as current
Not Provided
Not Provided
 
Angina Prevalence and Provider Evaluation of Angina Relief
Angina Prevalence and Provider Evaluation of Angina Relief

The purpose of this study is describe the frequency of chest pain and how chest pain impacts patients' quality of life in the outpatients with chronic coronary artery disease in contemporary cardiology practice settings.

The primary goals in the management of stable coronary artery disease (CAD) are to reduce risk factors for heart attack and to control the symptoms of angina (chest pain). Ideally angina is well controlled with medications alone, but invasive procedures are a valuable option for patients with persistent angina. The amount of angina among patients with stable CAD in the outpatient setting, however, is unknown. An Australian study reported that almost 1 in 3 patients with stable angina being treated by primary care doctors had angina at least once a week, which was associated with worse quality of life. We propose to examine the burden of angina in outpatients with stable CAD who are being medically managed by cardiologists in the United States through administration of a one-time survey. The information from this study could ultimately help improve management of stable CAD and angina and illuminate potential underuse of revascularization. While cardiologists are generally expected to provide better angina control than primary care doctors, establishing the prevalence of angina among the best providers will help with a framework for interpreting symptom control among other practitioners.

Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Outpatient cardilogy practice.

Stable Coronary Artery Disease (CAD).
Not Provided
Outpatient Coronary Artery Disease Patient
CAD patients being seen in a participating cardiology office for a scheduled clinic visit who agree to take the survey.
Beltrame JF, Weekes AJ, Morgan C, Tavella R, Spertus JA. The prevalence of weekly angina among patients with chronic stable angina in primary care practices: The Coronary Artery Disease in General Practice (CADENCE) Study. Arch Intern Med. 2009 Sep 14;169(16):1491-9.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Enrolling by invitation
1250
December 2014
September 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Coronary artery disease patients being seen in a participating cardiology office for a scheduled clinic visit who agree to take the survey.

Exclusion Criteria:

  • Too ill to take survey
  • Previously completed this survey
  • Refused to participate
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01705054
IN-US-259-0157
No
John A. Spertus, MD, MPH, Saint Luke's Health System
Saint Luke's Health System
Gilead Sciences
Principal Investigator: John A Spertus, MD, MPH Saint Luke's Hospital of Kansas City
Principal Investigator: Faraz Kureshi, MD Saint Luke's Hospital of Kansas City
Saint Luke's Health System
July 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP